The Endocrine Society hosts educational sessions to inform journalists as they research complex and emerging hormone health topics. Contact email@example.com for more information.
The State of Science on PFAS Chemicals - An Endocrine Society and Environmental Working Group Webinar
October 2, 2019 |
Presenters: Tasha Stoiber, PhD, and Scott Belcher, PhD
Endocrine Society and Environmental Working Group scientists explained what per- and polyfluoroalkyl substances (PFAS) chemicals are and how they threaten our health. Research has linked PFAS chemical exposure to cancer, damage to the reproductive and immune systems, thyroid disease and other health problems.
Is BPA Safe? An Endocrine Society Virtual News Conference
October 24, 2018 |
Presenters: Laura N. Vandenberg, PhD, and Heather Patisaul, PhD
Endocrine-disrupting chemical experts explored the threat BPA poses and the growing body of scientific evidence it harms health. Despite this evidence, the U.S. Food and Drug Administration (FDA) asserted that BPA is safe for use in food packaging, based on an initial report conducted as part of the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA).
Release of Executive Summary to EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-disrupting Chemicals
September 28, 2015 |
Presenter: Andrea C. Gore, PhD
Dr. Gore discussed emerging evidence that ties endocrine-disrupting chemical exposure to two of the biggest public health threats facing society – diabetes and obesity. The statement builds upon the Society’s groundbreaking 2009 report, which examined the state of scientific evidence on endocrine-disrupting chemicals (EDCs) and the risks posed to human health. In the ensuing years, additional research has found that exposure is associated with increased risk of developing diabetes and obesity. Mounting evidence also indicates EDC exposure is connected to infertility, hormone-related cancers, neurological issues and other disorders.
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
January 15, 2015 |
Presenter: Caroline M. Apovian, MD
Dr. Apovian shared highlights from the Society's newly released Clinical Practice Guideline on the use of prescription drugs to manage obesity. Developed by Endocrine Society obesity experts, the guideline provided recommendations on when and how to use prescription drugs to promote weight loss. The guideline also addressed the effect prescription medications for other conditions can have on weight.
The Science of Sex
February 7, 2014 |
Presenters: Nanette Santoro, MD and Bradley Anawalt, MD
Drs. Santoro and Anawalt discussed how the endocrine system’s inner workings influence romantic behavior. The speakers addressed the effects of the hormones prolactin, oxytocin, estrogen and testosterone on love and lust.
April 12, 2013 |
Presenter: R. Thomas Zoeller, MS, PhD
Dr. Zoeller examines what endocrine-disrupting chemicals are, how widespread they are in the environment and the impact they have on hormones. Dr. Zoeller discusses efforts by public health groups and policymakers to reduce the health risks posed by exposure.
Growth Hormone and Anti-Aging
Feb. 22, 2013 |
Presenter: Mark Molitch, MD
Dr. Molitch discusses what growth hormone is, when doctors may prescribe growth hormone treatment, and whether or not growth hormone use provides anti-aging effects
Oct. 26, 2012 |
Presenters: Robert Lustig, MD and Richard Atkinson, MD
Drs. Lustig and Atkinson address the causes of the childhood obesity epidemic. Are sugars and high fructose corn syrup to blame, or does childhood obesity trace its roots to maternal health before, during and just after pregnancy?